Basel Medical (BMGL) CFO files initial insider ownership Form 3

Rhea-AI Filing Summary

Basel Medical Group Ltd Chief Financial Officer Lu Jianing JN has filed an initial insider ownership report on Form 3. The filing lists no buy or sell transactions, and shows no derivative securities positions reported for this insider at this time.

Key Figures

Buy transactions: 0 transactions Sell transactions: 0 transactions Holding entries: 0 entries

3 metrics

Buy transactions 0 transactions Form 3 transaction summary for CFO Lu Jianing JN

Sell transactions 0 transactions Form 3 transaction summary for CFO Lu Jianing JN

Holding entries 0 entries Form 3 holding summary for CFO Lu Jianing JN

Key Terms

Form 3, reporting insider, Chief Financial Officer

3 terms

Form 3 regulatory

"has filed an initial insider ownership report on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting insider regulatory

"has been identified as a reporting insider of Basel Medical Group Ltd"

Chief Financial Officer financial

"Chief Financial Officer Lu Jianing JN has filed an initial insider ownership report"

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lu Jianing JN

(Last) (First) (Middle)

6 NAPIER ROAD,

UNIT #02-10/11 GLENEAGLES MEDICAL CENTRE

(Street)

SINGAPORE 258499

(City) (State) (Zip)

SINGAPORE

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Basel Medical Group Ltd [ BMGL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Jianing Lu	04/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Basel Medical Group (BMGL) Form 3 filing show for Lu Jianing JN?

The Form 3 shows that Chief Financial Officer Lu Jianing JN has been identified as a reporting insider of Basel Medical Group Ltd. It reports no transactions and no derivative securities positions for this insider in the information provided.

Did Basel Medical Group (BMGL) CFO Lu Jianing JN buy or sell any shares in this Form 3?

No, the Form 3 data shows zero buy and zero sell transactions for CFO Lu Jianing JN. The transaction summary reports no exercises, gifts, tax withholdings, or restructurings in connection with this initial ownership statement.

Are there any derivative securities reported for BMGL CFO Lu Jianing JN on this Form 3?

No derivative securities are reported for CFO Lu Jianing JN in this Form 3. The derivative summary is empty, and the transaction summary shows zero derivative transactions or option exercises associated with this insider at the time of filing.

What insider role does Lu Jianing JN hold at Basel Medical Group (BMGL)?

Lu Jianing JN is identified as an officer of Basel Medical Group Ltd, serving as Chief Financial Officer. The Form 3 confirms officer status and indicates the insider is not listed as a director or as a ten percent beneficial owner.

Does the Basel Medical Group (BMGL) Form 3 indicate any holdings for Lu Jianing JN?

The summarized data shows zero holding entries and no derivative positions for CFO Lu Jianing JN. This means the provided Form 3 information does not list specific share or option holdings for this insider at the time of the initial statement.